- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02266212
A Study on Analgesia and Related Outcomes for Patients With Tabacco Smoking
October 25, 2023 updated by: Yuan-Yi Chia, Kaohsiung Veterans General Hospital.
The Implications of Tobacco Smoking on Acute Postoperative Pain: A Prospective Observational Study
Numbers of postoperative PCA(Patient-Controlled Analgesia) related side effects among current, past and non smokers are determined by comparing and analyzing frequency distributions.
To determine whether smokers require more post operative opiate analgesics than others.
Multivariate analysis will be performed to identify the major and the minor factors predicting the use of postoperative pain therapy.
Our previous related study showed that the smoker male patients consumed more analgesics than those without smoking, but the female group showed the similar findings.
However, the case number, especially the female cases, is underpowered.
Investigators hope to increase the case number to have a better statistical and clinical significance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kaohsiung, Taiwan, 81362
- Kaohsiung Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients undergoing elective general surgery are assigned to current smokers(n=100) or past smokers(n=100) or never smokers(n=100) according to the questionnaires "Fagerstrom test for nicotine dependence" 1 day prior to the surgery.
Exclusion Criteria:
- the patients undergoing major thoracic cardiovascular surgery
- the patients with significant lung lesion
- the patients with conscious disturbance
- the patients with allergic history to morphine
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Smoke
Fagerstrom test for nicotine dependence
|
A sample of 5 ml arterial blood will be withdraw to test the arterial blood oxygen saturation, CO2 content, carbon monoxide (CO) content and carboxyhemoglobin (COHg).
|
Active Comparator: Pain
pain during post-operation Day1 to Day4
|
A sample of 5 ml arterial blood will be withdraw to test the arterial blood oxygen saturation, CO2 content, carbon monoxide (CO) content and carboxyhemoglobin (COHg).
|
Active Comparator: Morphine
Morphine consumption during post-operation Day1 to Day4
|
A sample of 5 ml arterial blood will be withdraw to test the arterial blood oxygen saturation, CO2 content, carbon monoxide (CO) content and carboxyhemoglobin (COHg).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Fagerstrom test for nicotine dependence
Time Frame: Post-operation Day1 to Day4
|
Post-operation Day1 to Day4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences in pain intensity between the three groups after postoperative analgesia.
Time Frame: Post-operation Day1 to Day4
|
Patients will give a pain score from 0 to 10. 10 is the most painful score.
|
Post-operation Day1 to Day4
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
side effects
Time Frame: Post-operation Day1 to Day4
|
site effects include dizzy, vomit, lethargic sleep and pruritus
|
Post-operation Day1 to Day4
|
Morphine consumption
Time Frame: Post-operation Day1 to Day4
|
Differences in postoperative morphine consumption between the 3 groups
|
Post-operation Day1 to Day4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
September 1, 2012
Study Completion (Actual)
September 1, 2012
Study Registration Dates
First Submitted
September 10, 2014
First Submitted That Met QC Criteria
October 12, 2014
First Posted (Estimated)
October 16, 2014
Study Record Updates
Last Update Posted (Actual)
October 27, 2023
Last Update Submitted That Met QC Criteria
October 25, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- VGHKS101-016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Current Smokers
-
Bionorica SECompletedCurrent SmokersBelgium
-
Imperial College LondonAstraZenecaWithdrawnCOPD Patients | Current Smokers | Healthy Non-smokersUnited Kingdom
-
Philip Morris Products S.A.CompletedSmokers | Never SmokersUnited States
-
Universitätsmedizin MannheimCompletedHealthy Subjects | Non-smokers | Smokers
-
Helsinn Healthcare SACelerionCompletedHealthy Volunteers | Non-smokers | Moderate to Heavy SmokersUnited States
-
A. Eden EvinsCompleted
-
Nikki Nollen, PhD, MACompleted
-
Memorial Sloan Kettering Cancer CenterNYU Langone Health; Ralph Lauren Center for Cancer Care and Prevention; Sophie... and other collaboratorsCompleted
Clinical Trials on 5 ml arterial blood
-
University Hospital, GrenobleCompletedMild Traumatic Brain InjuryFrance, Spain
-
Western University, CanadaBayer; University of Alberta; Queen's University; Canadian Cardiovascular SocietyNot yet recruitingHeart Transplant Rejection
-
Assistance Publique - Hôpitaux de ParisBioMérieuxActive, not recruitingHeart Transplant Infection | Heart Transplant Rejection | VirusFrance
-
St. Jude Children's Research HospitalNational Eye Institute (NEI)Completed
-
Northwestern UniversityCompletedSurgery | HypoventilationUnited States
-
Centre Hospitalier Universitaire DijonCompleted
-
Inonu UniversityNot yet recruitingSepsis | Acute Kidney Injury
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Akdeniz UniversityCompletedHyperoxia | Kidney Transplant; Complications | Graft DysfunctionTurkey
-
Institut CurieCompletedVolunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 InfectionFrance